Grants and Contributions:
Title:
ARP - Acoustic biomarkers for the rapid detection of newborn perinatal asphyxia
Agreement Number:
984539
Agreement Value:
$50,000.00
Agreement Date:
Nov 1, 2021 - Jul 31, 2022
Description:
Analysis of new clinical data in view of developing acoustic biomarkers that can be leveraged in AI models for detection of asphyxia from the newborn cry.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2S 3H1
Reference Number:
172-2021-2022-Q4-984539
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
720341122
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
May 11, 2022
Recipient's Operating Name:
Santé Ubenwa
Recipient's Legal Name:
Solutions d'intelligence Ubenwa Inc.
Federal Riding Name:
Rosemont--La Petite-Patrie
Federal Riding Number:
24064
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211
Amendments: